Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • No shortage of stents...

    No shortage of stents in the country: NPPA

    Written by supriya kashyap kashyap Published On 2017-03-08T11:01:50+05:30  |  Updated On 8 March 2017 11:01 AM IST
    No shortage of stents in the country: NPPA

    New Delhi : Drug pricing regulator NPPA said there is no shortage of stents in the country and manufacturers have assured it of smooth supplies.


    The National Pharmaceutical Pricing Authority (NPPA) met stent makers and importers today to discuss issues like pricing and availability of the medical device.


    "There is no shortage of stents at present. We have not received any complaints regarding this either from the state drug controllers or from the hospitals," NPPA Chairman Bhupendra Singh told .


    The firms who attended the meeting have assured the regulator of smooth supply of stents, he added.


    Last week, the regulator had invited 16 firms, including Abbott Healthcare, Boston Scientific India and Sahajanand Medical Technologies, for the meeting.


    This is the second meeting the government has held with stent manufacturers and importers.


    The government has already made it mandatory for manufacturers to maintain production and supply of coronary stents by invoking an emergency clause under drug price control law, citing reports of shortage in market.


    "After due deliberations on the current situation and alternatives available with the government to resume normal supply of the coronary stents, it has been decided to invoke the powers of Section 3 (i) of DPCO, 2013," the Department of Pharmaceuticals had said in a letter to stent makers last month.


    In a major relief to lakhs of cardiac patients, the government last month had slashed the prices of the coronary stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 for the drug eluting variety.

    AbbottBhupendra SinghBostonCoronary StentsNational Pharmaceutical Pricing AuthorityNPPAStent
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok